Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 22 entries
Sorted by: Best Match Show Resources per page
Treatment strategies and clinical outcomes of locally advanced pancreatic cancer patients treated at high-volume facilities and academic centers.

Advances in radiation oncology

David JM, Kim S, Placencio-Hickok VR, Torosian A, Hendifar A, Tuli R.
PMID: 31011675
Adv Radiat Oncol. 2018 Nov 09;4(2):302-313. doi: 10.1016/j.adro.2018.10.006. eCollection 2019.

PURPOSE: Locally advanced pancreatic cancer (LAPC) treatment has varying practice patterns with poor outcomes. We investigated treatment using single-agent chemotherapy and multiagent chemotherapy (MAC) with or without radiation therapy (RT) at high-volume facilities (HVFs) and academic centers (ACs).METHODS AND...

Cite
David JM, Kim S, Placencio-Hickok VR, et al. Treatment strategies and clinical outcomes of locally advanced pancreatic cancer patients treated at high-volume facilities and academic centers. Adv Radiat Oncol. 2018;4(2):302-313doi: 10.1016/j.adro.2018.10.006.
David, J. M., Kim, S., Placencio-Hickok, V. R., Torosian, A., Hendifar, A., & Tuli, R. (2019). Treatment strategies and clinical outcomes of locally advanced pancreatic cancer patients treated at high-volume facilities and academic centers. Advances in radiation oncology, 4(2), 302-313. https://doi.org/10.1016/j.adro.2018.10.006
David, John M, et al. "Treatment strategies and clinical outcomes of locally advanced pancreatic cancer patients treated at high-volume facilities and academic centers." Advances in radiation oncology vol. 4,2 (2019): 302-313. doi: https://doi.org/10.1016/j.adro.2018.10.006
David JM, Kim S, Placencio-Hickok VR, Torosian A, Hendifar A, Tuli R. Treatment strategies and clinical outcomes of locally advanced pancreatic cancer patients treated at high-volume facilities and academic centers. Adv Radiat Oncol. 2018 Nov 09;4(2):302-313. doi: 10.1016/j.adro.2018.10.006. eCollection 2019. PMID: 31011675; PMCID: PMC6460104.
Copy Download .nbib Format: NLM
Combined Candida dubliniensis and Candida albicans Keratitis following a Chemical Injury.

Case reports in ophthalmological medicine

Torosian J, Mauger T.
PMID: 31214370
Case Rep Ophthalmol Med. 2019 May 13;2019:7628126. doi: 10.1155/2019/7628126. eCollection 2019.

No abstract available.

Cite
Torosian J, Mauger T. Combined Candida dubliniensis and Candida albicans Keratitis following a Chemical Injury. Case Rep Ophthalmol Med. 2019;2019:7628126doi: 10.1155/2019/7628126.
Torosian, J., & Mauger, T. (2019). Combined Candida dubliniensis and Candida albicans Keratitis following a Chemical Injury. Case reports in ophthalmological medicine, 20197628126. https://doi.org/10.1155/2019/7628126
Torosian, Justin, and Mauger, Thomas. "Combined Candida dubliniensis and Candida albicans Keratitis following a Chemical Injury." Case reports in ophthalmological medicine vol. 2019 (2019): 7628126. doi: https://doi.org/10.1155/2019/7628126
Torosian J, Mauger T. Combined Candida dubliniensis and Candida albicans Keratitis following a Chemical Injury. Case Rep Ophthalmol Med. 2019 May 13;2019:7628126. doi: 10.1155/2019/7628126. eCollection 2019. PMID: 31214370; PMCID: PMC6535822.
Copy Download .nbib Format: NLM
Reconfigurable system for automated optimization of diverse chemical reactions.

Science (New York, N.Y.)

Bédard AC, Adamo A, Aroh KC, Russell MG, Bedermann AA, Torosian J, Yue B, Jensen KF, Jamison TF.
PMID: 30237351
Science. 2018 Sep 21;361(6408):1220-1225. doi: 10.1126/science.aat0650.

Chemical synthesis generally requires labor-intensive, sometimes tedious trial-and-error optimization of reaction conditions. Here, we describe a plug-and-play, continuous-flow chemical synthesis system that mitigates this challenge with an integrated combination of hardware, software, and analytics. The system software controls the...

Cite
Bédard AC, Adamo A, Aroh KC, et al. Reconfigurable system for automated optimization of diverse chemical reactions. Science. 2018;361(6408):1220-1225doi: 10.1126/science.aat0650.
Bédard, A. C., Adamo, A., Aroh, K. C., Russell, M. G., Bedermann, A. A., Torosian, J., Yue, B., Jensen, K. F., & Jamison, T. F. (2018). Reconfigurable system for automated optimization of diverse chemical reactions. Science (New York, N.Y.), 361(6408), 1220-1225. https://doi.org/10.1126/science.aat0650
Bédard, Anne-Catherine, et al. "Reconfigurable system for automated optimization of diverse chemical reactions." Science (New York, N.Y.) vol. 361,6408 (2018): 1220-1225. doi: https://doi.org/10.1126/science.aat0650
Bédard AC, Adamo A, Aroh KC, Russell MG, Bedermann AA, Torosian J, Yue B, Jensen KF, Jamison TF. Reconfigurable system for automated optimization of diverse chemical reactions. Science. 2018 Sep 21;361(6408):1220-1225. doi: 10.1126/science.aat0650. PMID: 30237351.
Copy Download .nbib Format: NLM
Combined morphologic and metabolic pipeline for Positron emission tomography/computed tomography based radiotherapy response evaluation in locally advanced pancreatic adenocarcinoma.

Physics and imaging in radiation oncology

Lao Y, David J, Torosian A, Placencio V, Wang Y, Hendifar A, Yang W, Tuli R.
PMID: 32190750
Phys Imaging Radiat Oncol. 2019 Jan;9:28-34. doi: 10.1016/j.phro.2018.12.003. Epub 2019 Jan 04.

BACKGROUND AND PURPOSE: Adaptive radiation planning for pancreatic adenocarcinoma (PA) relies on accurate treatment response assessment, while traditional response evaluation criteria inefficiently characterize tumors with complex morphological features or intrinsically low metabolism. To better assess treatment response of PA,...

Cite
Lao Y, David J, Torosian A, et al. Combined morphologic and metabolic pipeline for Positron emission tomography/computed tomography based radiotherapy response evaluation in locally advanced pancreatic adenocarcinoma. Phys Imaging Radiat Oncol. 2019;9:28-34doi: 10.1016/j.phro.2018.12.003.
Lao, Y., David, J., Torosian, A., Placencio, V., Wang, Y., Hendifar, A., Yang, W., & Tuli, R. (2019). Combined morphologic and metabolic pipeline for Positron emission tomography/computed tomography based radiotherapy response evaluation in locally advanced pancreatic adenocarcinoma. Physics and imaging in radiation oncology, 928-34. https://doi.org/10.1016/j.phro.2018.12.003
Lao, Yi, et al. "Combined morphologic and metabolic pipeline for Positron emission tomography/computed tomography based radiotherapy response evaluation in locally advanced pancreatic adenocarcinoma." Physics and imaging in radiation oncology vol. 9 (2019): 28-34. doi: https://doi.org/10.1016/j.phro.2018.12.003
Lao Y, David J, Torosian A, Placencio V, Wang Y, Hendifar A, Yang W, Tuli R. Combined morphologic and metabolic pipeline for Positron emission tomography/computed tomography based radiotherapy response evaluation in locally advanced pancreatic adenocarcinoma. Phys Imaging Radiat Oncol. 2019 Jan;9:28-34. doi: 10.1016/j.phro.2018.12.003. Epub 2019 Jan 04. PMID: 32190750; PMCID: PMC7079767.
Copy Download .nbib Format: NLM
Surface plasma-enhanced internal photoemission in gallium arsenide Schottky diodes.

Applied optics

Torosian KM, Karakashian AS, Teng YY.
PMID: 20489936
Appl Opt. 1987 Jul 01;26(13):2650-2. doi: 10.1364/AO.26.002650.

An aluminum on n-type gallium arsenide Schottky diode with a prism coupler on the front face was illuminated by a p-polarized Nd:YAG laser to excite the surface plasma resonance in the aluminum barrier contact. The internal photoemission current and...

Cite
Torosian KM, Karakashian AS, Teng YY. Surface plasma-enhanced internal photoemission in gallium arsenide Schottky diodes. Appl Opt. 1987;26(13):2650-2doi: 10.1364/AO.26.002650.
Torosian, K. M., Karakashian, A. S., & Teng, Y. Y. (1987). Surface plasma-enhanced internal photoemission in gallium arsenide Schottky diodes. Applied optics, 26(13), 2650-2. https://doi.org/10.1364/AO.26.002650
Torosian, K M, et al. "Surface plasma-enhanced internal photoemission in gallium arsenide Schottky diodes." Applied optics vol. 26,13 (1987): 2650-2. doi: https://doi.org/10.1364/AO.26.002650
Torosian KM, Karakashian AS, Teng YY. Surface plasma-enhanced internal photoemission in gallium arsenide Schottky diodes. Appl Opt. 1987 Jul 01;26(13):2650-2. doi: 10.1364/AO.26.002650. PMID: 20489936.
Copy Download .nbib Format: NLM
Integrating spiritual assessment into a psychiatric inpatient unit.

Psychiatry (Edgmont (Pa. : Township))

McGee MD, Torosian J.
PMID: 20877557
Psychiatry (Edgmont). 2006 Dec;3(12):60-4.

This paper describes a successful effort to quantitatively assess and address different domains of spirituality as part of a "biopsychosocialspiritual" treatment model on an inpatient psychiatry unit. A "spiritual health profile" can be easily obtained and integrated into the...

Cite
McGee MD, Torosian J. Integrating spiritual assessment into a psychiatric inpatient unit. Psychiatry (Edgmont). 2006;3(12):60-4
McGee, M. D., & Torosian, J. (2006). Integrating spiritual assessment into a psychiatric inpatient unit. Psychiatry (Edgmont (Pa. : Township)), 3(12), 60-4.
McGee, Michael D, and Torosian, Jennifer. "Integrating spiritual assessment into a psychiatric inpatient unit." Psychiatry (Edgmont (Pa. : Township)) vol. 3,12 (2006): 60-4.
McGee MD, Torosian J. Integrating spiritual assessment into a psychiatric inpatient unit. Psychiatry (Edgmont). 2006 Dec;3(12):60-4. PMID: 20877557; PMCID: PMC2945898.
Copy Download .nbib Format: NLM
The dignity of older individuals with Alzheimer's disease and related dementias: A scoping review.

Dementia (London, England)

Torossian MR.
PMID: 34039079
Dementia (London). 2021 Nov;20(8):2891-2915. doi: 10.1177/14713012211021722. Epub 2021 May 27.

BACKGROUND: Supporting human dignity is the essence of delivery of care. Dignity is one's sense of self-value that is influenced by the perceived value attributed to the individual from others. Individuals with Alzheimer's disease and related dementias (ADRD) are...

Cite
Torossian MR. The dignity of older individuals with Alzheimer's disease and related dementias: A scoping review. Dementia (London). 2021;20(8):2891-2915doi: 10.1177/14713012211021722.
Torossian, M. R. (2021). The dignity of older individuals with Alzheimer's disease and related dementias: A scoping review. Dementia (London, England), 20(8), 2891-2915. https://doi.org/10.1177/14713012211021722
Torossian, Maral R. "The dignity of older individuals with Alzheimer's disease and related dementias: A scoping review." Dementia (London, England) vol. 20,8 (2021): 2891-2915. doi: https://doi.org/10.1177/14713012211021722
Torossian MR. The dignity of older individuals with Alzheimer's disease and related dementias: A scoping review. Dementia (London). 2021 Nov;20(8):2891-2915. doi: 10.1177/14713012211021722. Epub 2021 May 27. PMID: 34039079.
Copy Download .nbib Format: NLM
Complete Genome Sequences of Cluster A6 and Cluster G1 Mycobacterium smegmatis Phages Hoot and Jolene.

Microbiology resource announcements

Thompson J, Özdemir A, Topchyan AM, Torosian M, Thymianos VZ, Eagle A, McCormick J, Boyles LKG, Benito AA, Regner K, Strong C, Tsourkas PK.
PMID: 34672710
Microbiol Resour Announc. 2021 Oct 21;10(42):e0057821. doi: 10.1128/MRA.00578-21. Epub 2021 Oct 21.

We present the complete genome sequences of Mycobacterium smegmatis phages Hoot and Jolene, isolated in Las Vegas, NV. The phages were isolated and annotated by students enrolled in an undergraduate research course at the University of Nevada, Las Vegas....

Cite
Thompson J, Özdemir A, Topchyan AM, et al. Complete Genome Sequences of Cluster A6 and Cluster G1 Mycobacterium smegmatis Phages Hoot and Jolene. Microbiol Resour Announc. 2021;10(42):e0057821doi: 10.1128/MRA.00578-21.
Thompson, J., Özdemir, A., Topchyan, A. M., Torosian, M., Thymianos, V. Z., Eagle, A., McCormick, J., Boyles, L. K. G., Benito, A. A., Regner, K., Strong, C., & Tsourkas, P. K. (2021). Complete Genome Sequences of Cluster A6 and Cluster G1 Mycobacterium smegmatis Phages Hoot and Jolene. Microbiology resource announcements, 10(42), e0057821. https://doi.org/10.1128/MRA.00578-21
Thompson, Jon, et al. "Complete Genome Sequences of Cluster A6 and Cluster G1 Mycobacterium smegmatis Phages Hoot and Jolene." Microbiology resource announcements vol. 10,42 (2021): e0057821. doi: https://doi.org/10.1128/MRA.00578-21
Thompson J, Özdemir A, Topchyan AM, Torosian M, Thymianos VZ, Eagle A, McCormick J, Boyles LKG, Benito AA, Regner K, Strong C, Tsourkas PK. Complete Genome Sequences of Cluster A6 and Cluster G1 Mycobacterium smegmatis Phages Hoot and Jolene. Microbiol Resour Announc. 2021 Oct 21;10(42):e0057821. doi: 10.1128/MRA.00578-21. Epub 2021 Oct 21. PMID: 34672710; PMCID: PMC8530025.
Copy Download .nbib Format: NLM
Correction to: Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial.

Bone marrow transplantation

Hölig K, Schmidt H, Hütter G, Kramer M, Teipel R, Heidrich K, Zimmer K, Heidenreich F, Blechschmidt M, Torosian T, Ordemann R, Kroschinsky F, Rücker-Braun E, Gopsca L, Wagner-Drouet EM, Oelschlaegel U, Schmidt AH, Bornhäuser M, Ehninger G, Schetelig J.
PMID: 34773089
Bone Marrow Transplant. 2021 Nov 12; doi: 10.1038/s41409-021-01523-3. Epub 2021 Nov 12.

No abstract available.

Cite
Hölig K, Schmidt H, Hütter G, et al. Correction to: Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial. Bone Marrow Transplant. 2021;doi: 10.1038/s41409-021-01523-3.
Hölig, K., Schmidt, H., Hütter, G., Kramer, M., Teipel, R., Heidrich, K., Zimmer, K., Heidenreich, F., Blechschmidt, M., Torosian, T., Ordemann, R., Kroschinsky, F., Rücker-Braun, E., Gopsca, L., Wagner-Drouet, E. M., Oelschlaegel, U., Schmidt, A. H., Bornhäuser, M., Ehninger, G., & Schetelig, J. (2021). Correction to: Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial. Bone marrow transplantation, . https://doi.org/10.1038/s41409-021-01523-3
Hölig, Kristina, et al. "Correction to: Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial." Bone marrow transplantation vol. (2021). doi: https://doi.org/10.1038/s41409-021-01523-3
Hölig K, Schmidt H, Hütter G, Kramer M, Teipel R, Heidrich K, Zimmer K, Heidenreich F, Blechschmidt M, Torosian T, Ordemann R, Kroschinsky F, Rücker-Braun E, Gopsca L, Wagner-Drouet EM, Oelschlaegel U, Schmidt AH, Bornhäuser M, Ehninger G, Schetelig J. Correction to: Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial. Bone Marrow Transplant. 2021 Nov 12; doi: 10.1038/s41409-021-01523-3. Epub 2021 Nov 12. PMID: 34773089.
Copy Download .nbib Format: NLM
Sleep, Mild Cognitive Impairment, and Interventions for Sleep Improvement: An Integrative Review.

Western journal of nursing research

Torossian M, Fiske SM, Jacelon CS.
PMID: 33455559
West J Nurs Res. 2021 Jan 16;193945920986907. doi: 10.1177/0193945920986907. Epub 2021 Jan 16.

Sleep disturbance in mild cognitive impairment (MCI) is associated with progression to Alzheimer's disease (AD), more severe AD symptoms, and worse health outcomes. The aim of this review was to examine the relationship between sleep and MCI, and the...

Cite
Torossian M, Fiske SM, Jacelon CS. Sleep, Mild Cognitive Impairment, and Interventions for Sleep Improvement: An Integrative Review. West J Nurs Res. 2021;193945920986907doi: 10.1177/0193945920986907.
Torossian, M., Fiske, S. M., & Jacelon, C. S. (2021). Sleep, Mild Cognitive Impairment, and Interventions for Sleep Improvement: An Integrative Review. Western journal of nursing research, 193945920986907. https://doi.org/10.1177/0193945920986907
Torossian, Maral, et al. "Sleep, Mild Cognitive Impairment, and Interventions for Sleep Improvement: An Integrative Review." Western journal of nursing research vol. (2021): 193945920986907. doi: https://doi.org/10.1177/0193945920986907
Torossian M, Fiske SM, Jacelon CS. Sleep, Mild Cognitive Impairment, and Interventions for Sleep Improvement: An Integrative Review. West J Nurs Res. 2021 Jan 16;193945920986907. doi: 10.1177/0193945920986907. Epub 2021 Jan 16. PMID: 33455559; PMCID: PMC8282804.
Copy Download .nbib Format: NLM
Correction to: Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial.

Bone marrow transplantation

Hölig K, Schmidt H, Hütter G, Kramer M, Teipel R, Heidrich K, Zimmer K, Heidenreich F, Blechschmidt M, Torosian T, Ordemann R, Kroschinsky F, Rücker-Braun E, Gopsca L, Wagner-Drouet EM, Oelschlaegel U, Schmidt AH, Bornhäuser M, Ehninger G, Schetelig J.
PMID: 34773089
Bone Marrow Transplant. 2022 Jan;57(1):143. doi: 10.1038/s41409-021-01523-3.

No abstract available.

Cite
Hölig K, Schmidt H, Hütter G, et al. Correction to: Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial. Bone Marrow Transplant. 2022;57(1):143doi: 10.1038/s41409-021-01523-3.
Hölig, K., Schmidt, H., Hütter, G., Kramer, M., Teipel, R., Heidrich, K., Zimmer, K., Heidenreich, F., Blechschmidt, M., Torosian, T., Ordemann, R., Kroschinsky, F., Rücker-Braun, E., Gopsca, L., Wagner-Drouet, E. M., Oelschlaegel, U., Schmidt, A. H., Bornhäuser, M., Ehninger, G., & Schetelig, J. (2022). Correction to: Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial. Bone marrow transplantation, 57(1), 143. https://doi.org/10.1038/s41409-021-01523-3
Hölig, Kristina, et al. "Correction to: Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial." Bone marrow transplantation vol. 57,1 (2022): 143. doi: https://doi.org/10.1038/s41409-021-01523-3
Hölig K, Schmidt H, Hütter G, Kramer M, Teipel R, Heidrich K, Zimmer K, Heidenreich F, Blechschmidt M, Torosian T, Ordemann R, Kroschinsky F, Rücker-Braun E, Gopsca L, Wagner-Drouet EM, Oelschlaegel U, Schmidt AH, Bornhäuser M, Ehninger G, Schetelig J. Correction to: Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial. Bone Marrow Transplant. 2022 Jan;57(1):143. doi: 10.1038/s41409-021-01523-3. PMID: 34773089.
Copy Download .nbib Format: NLM
Therapeutic implications of activating noncanonical PIK3CA mutations in head and neck squamous cell carcinoma.

The Journal of clinical investigation

Jin N, Keam B, Cho J, Lee MJ, Kim HR, Torosyan H, Jura N, Ng PK, Mills GB, Li H, Zeng Y, Barbash Z, Tarcic G, Kang H, Bauman JE, Kim MO, VanLandingham NK, Swaney DL, Krogan NJ, Johnson DE, Grandis JR.
PMID: 34779417
J Clin Invest. 2021 Nov 15;131(22). doi: 10.1172/JCI150335.

Alpelisib selectively inhibits the p110α catalytic subunit of PI3Kα and is approved for treatment of breast cancers harboring canonical PIK3CA mutations. In head and neck squamous cell carcinoma (HNSCC), 63% of PIK3CA mutations occur at canonical hotspots. The oncogenic...

Cite
Jin N, Keam B, Cho J, et al. Therapeutic implications of activating noncanonical PIK3CA mutations in head and neck squamous cell carcinoma. J Clin Invest. 2021;131(22)doi: 10.1172/JCI150335.
Jin, N., Keam, B., Cho, J., Lee, M. J., Kim, H. R., Torosyan, H., Jura, N., Ng, P. K., Mills, G. B., Li, H., Zeng, Y., Barbash, Z., Tarcic, G., Kang, H., Bauman, J. E., Kim, M. O., VanLandingham, N. K., Swaney, D. L., Krogan, N. J., Johnson, D. E., & Grandis, J. R. (2021). Therapeutic implications of activating noncanonical PIK3CA mutations in head and neck squamous cell carcinoma. The Journal of clinical investigation, 131(22), . https://doi.org/10.1172/JCI150335
Jin, Nan, et al. "Therapeutic implications of activating noncanonical PIK3CA mutations in head and neck squamous cell carcinoma." The Journal of clinical investigation vol. 131,22 (2021). doi: https://doi.org/10.1172/JCI150335
Jin N, Keam B, Cho J, Lee MJ, Kim HR, Torosyan H, Jura N, Ng PK, Mills GB, Li H, Zeng Y, Barbash Z, Tarcic G, Kang H, Bauman JE, Kim MO, VanLandingham NK, Swaney DL, Krogan NJ, Johnson DE, Grandis JR. Therapeutic implications of activating noncanonical PIK3CA mutations in head and neck squamous cell carcinoma. J Clin Invest. 2021 Nov 15;131(22). doi: 10.1172/JCI150335. PMID: 34779417; PMCID: PMC8592538.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 22 entries